Dext Capital names Pack healthcare sales channel leader. In his new role, John Pack will lead the healthcare sales channel, working with health systems, manufacturers and distributors to build vendor programs and grow originations. Dext Capital appointed John Pack as healthcare sales channel leader. Pack brings a wealth of expertise in healthcare finance and vendor program development. He most recently served as senior vice president of healthcare originations and business development at Mitsubishi HC Capital, where he built relationships with health systems, OEMs and distributors, and put disciplined pipeline management practices in place. His experience includes serving as senior vice president and market director of healthcare finance at Santander Bank, leading vendor program and business development teams at TIAA Bank, formerly EverBank Commercial Finance, and a pivotal role at Key Equipment Finance, where he developed vendor program relationships with national and global healthcare organizations. In his new role, Pack will lead the healthcare sales channel, working with health systems, manufacturers and distributors to build vendor programs and grow originations. "John brings extensive experience in healthcare finance with a proven track record of building high performing teams and programs," Jeff Wertz, chief sales officer at Dext Capital, said. "His depth of expertise aligns perfectly with Dext Capital. Healthcare has been foundational to Dext from the very beginning and remains central to our strategy, making John an outstanding fit to lead and grow our portfolio. We're excited to welcome him to the team."

Dext Capital is preparing its second securitisation of 2025, issuing $439.14 million in equipment loan and lease contracts backed primarily by enterprise technology and surgical equipment. The Dext ABS 2025-2 deal includes a $65 million prefunding account, representing 15% of the total collateral balance. The notes carry legal final maturity dates ranging from November 2026 for class A1 notes through October 2036 for class D notes. S&P Global Ratings and Moody's Ratings assessed the transaction, with Moody's assigning ratings from Aaa to Baa3 across the capital structure. The collateral pool comprises 20.1% enterprise technology equipment, 10.9% surgical equipment and 1.5% general technology, with an average contract balance of $90,162. Dext Capital serves as originator and servicer, though Moody's noted the company's limited historical performance introduces uncertainty regarding future portfolio performance.